TNF-α increases ip-10 expression in MCF-7 breast cancer cells via activation of the JNK/c-jun pathways

Research output: Contribution to journalArticlepeer-review

Abstract

IP-10 (also called CXCL10) plays a significant role in leukocyte homing to inflamed tissues, and increased IP-10 levels are associated with the pathologies of various inflammatory disorders, including type 2 diabetes, atherosclerosis, and cancer. TNF-α is a potent activator of immune cells and induces inflammatory cytokine expression in these cells. However, it is unclear whether TNF-α is able to induce IP-10 expression in MCF-7 breast cancer cells. We therefore determined IP-10 expression in TNF-α-treated MCF-7 cells and investigated the mechanism involved. Our data show that TNF-α induced/upregulated the IP-10 expression at both mRNA and protein levels in MCF-7 cells. Inhibition of JNK (SP600125) significantly suppressed the TNF-α-induced IP-10 in MCF-7 cells, while the inhibition of p38 MAPK (SB203580), MEK1/2 (U0126), and ERK1/2 (PD98059) had no significant effect. Furthermore, TNF-α-induced IP-10 expression was abolished in MCF-7 cells deficient in JNK. Similar results were obtained using MCF-7 cells deficient in c-Jun. Moreover, the JNK kinase inhibitor markedly reduced the TNF-α-induced JNK and c-Jun phosphorylation. The kinase activity of JNK induced by TNF-α stimulation of MCF-7 cells was significantly inhibited by SP600125. Altogether, our novel findings provide the evidence that TNF-α induces IP-10 expression in MCF-7 breast cancer cells via activation of the JNK/c-Jun signaling pathway.

Original languageEnglish
Article number1355
JournalBiomolecules
Volume11
Issue number9
DOIs
Publication statusPublished - 13 Sep 2021

Keywords

  • C-Jun
  • IP-10/CXCL10
  • JNK
  • MCF-7
  • TNF-α

Fingerprint

Dive into the research topics of 'TNF-α increases ip-10 expression in MCF-7 breast cancer cells via activation of the JNK/c-jun pathways'. Together they form a unique fingerprint.

Cite this